Sotorasib is a synthetic compound used as an active pharmaceutical ingredient. It acts as an inhibitor of the RAS GTPase family and is investigated for its role in targeting the G12C mutation in the KRAS protein associated with certain cancers.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2296729-00-3
Sotorasib
active pharmaceutical ingredient
(11alpha,13E)-11-hydroxy-9,15-dioxoprost-13-en-1-oic acid
prostaglandin active pharmaceutical ingredient
Riociguat metabolite M3
active pharmaceutical ingredient metabolite
Atazanavir sulfate
active pharmaceutical ingredient
Terbutaline
beta-adrenergic agonist bronchodilator
6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one
NXQKSXLFSAEQCZ-SFHVURJKSA-N
C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C